Long-acting insulin analogs and the risk of diabetic ketoacidosis in children and adolescents with type 1 diabetes: a prospective study of 10,682 patients from 271 institutions.

In a previous smaller study, a nonsignificant trend of less DKA episodes was described in children injecting long-acting insulin analogs ( 5 ), but mean patient age (6.5 years) and overall DKA risk were lower in that series, which may account for the differences to our findings.

also in 5,406 other papers